Type 2 & other diabetes

A Randomized Clinical Trial of a Culturally Tailored Diabetes Education Curriculum With and Without Real-Time Continuous Glucose Monitoring in a Latino Population With Type 2 Diabetes: The CUT-DM With Continuous Glucose Monitoring Study

J Diabetes Sci TechnolPublished Randomised controlled trial

Authors' conclusion

In a Latino type 2 diabetes population that was primarily noninsulin-requiring, virtually delivered, culturally tailored education improved HbA1c, with RT-CGM conferring greater improvement.

Study context

Population
Latinos with uncontrolled (HbA1c >8.0%) T2D, not on intensive insulin management, Federally Qualified Health Center (FQHC); mean age 46 years, 44% female, 68% uninsured, 26% basal insulin onlyrandomized 1:1
Participants
120 participants
Comparison
Culturally tailored education plus cyclic rtCGM vs education only
Primary endpoint
Change in HbA1c from baseline
Follow-up
12 weeks
Methodological detailsopen-label, single-centre (Federally Qualified Health Center), Mean 1-hour session attendance 7.0 (±4.4); mean real-time continuous glucose monitoring (RT-CGM) wear 27.9 (±20.5) days
  • Open-label
  • Single-centre (Federally Qualified Health Center)
  • Mean 1-hour session attendance 7.0 (±4.4); mean RT-CGM wear 27.9 (±20.5) days

Primary result

As reported in the abstract

HbA1c reduction

P = 0.04

Secondary outcomes

HbA1c reduction, overall · 12 weeks

Overall HbA1c reduction 1.9% (95% CI 1.5-2.3), P < .001

HbA1c · 24 weeks

Overall HbA1c reduction maintained but between-group differences attenuated

Original publication

A Randomized Clinical Trial of a Culturally Tailored Diabetes Education Curriculum With and Without Real-Time Continuous Glucose Monitoring in a Latino Population With Type 2 Diabetes: The CUT-DM With Continuous Glucose Monitoring Study. J Diabetes Sci Technol. Published 10 April 2025. doi:10.1177/19322968251331526

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.